Prince Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2024: USD 0.57

Prince Pharmaceutical Co., Ltd. Revenue Per Share is USD 0.57 for the year ending December 31, 2024, a -16.65% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Prince Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023 was USD 0.69, a -1.57% change year over year.
  • Prince Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 0.70, a 46.08% change year over year.
  • Prince Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 0.48, a 49.15% change year over year.
  • Prince Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 0.32, a 23.48% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio